Subnanometer metal organic framework pores can selectively transport alkali metal ions of the same valence and similar sizes.

No abstract

Macrocyclic chemistry has relied on the dominance of some key cavitands, including cyclodextrins, calixarenes, cyclophanes, and cucurbiturils, to advance the field of host-guest science. Very few of the many other cavitands introduced by chemists during these past few decades have been developed to near the extent of these four key players. A relatively new family of macrocycles that are becoming increasingly dominant in the field of macrocyclic chemistry are the pillar[n]arenes composed of n hydroquinone rings connected in their 2- and 5-positions by methylene bridges. This substitution pattern creates a cylindrical or pillar-like structure that has identical upper and lower rims. The preparation of pillar[n]arenes is facile, with pillar[5]- through pillar[7]arene being readily accessible and the larger macrocycles (n = 8-14) being accessible in diminishing yields. The rigid pillar[n]arene cavities are highly π-electron-rich on account of the n activated aromatic faces pointing toward their centers, allowing the cavities to interact strongly with a range of π-electron-deficient guests including pyridiniums, alkylammoniums, and imidazoliums. The substitution pattern of pillar[n]arenes bestows chirality onto the macrocycle in the form of n chiral planes. The absolute configuration of the chiral planes in pillar[n]arenes can be either fixed or rapidly undergoing inversion. The future of pillar[n]arenes is going to be dependent on their ability to fulfill specific applications. Chemical modification of the parent pillar[n]arenes lets us create functionalized hosts with anticipated chemical or physical properties. The featured potential applications of pillar[n]arenes to date are far reaching and include novel hosts with relevance to nanotechnology, materials science, and medicine. Pillar[n]arenes have an overwhelming advantage over other hosts since the number of ways available to incorporate handles into their structures are diverse and easy to implement. In this Account, we describe the routes to chemically modified pillar[n]arenes by discussing the chemistry of their functionalization: monofunctionalization, difunctionalization, rim differentiation, perfunctionalization, and phenylene substitution. We assess the synthetic complications of employing these functionalization procedures and survey the potential applications and novel properties that arise with these functionalized pillar[n]arenes. We also highlight the challenges and the synthetic approaches that have yet to be fully explored for the selective chemical modification of these hosts. Finally, we examine a related class of macrocycles and consider their future applications. We trust that this Account will stimulate the development of new methods for functionalizing these novel hosts to realize pillar[n]arene-containing compounds capable of finding applications.

In order to selectively target malignant cells and eliminate severe side effects of conventional chemotherapy, biocompatible and redox-responsive hollow nanocontainers with tumor specificity were fabricated. The mechanized nanocontainers were achieved by anchoring mechanically interlocked molecules, i.e., [2]rotaxanes, onto the orifices of hollow mesoporous silica nanoparticles via disulfide bonds as intermediate linkers for intracellular glutathione-triggered drug release. The [2]rotaxane employed was mainly composed of U.S. Food and Drug Administration approved tetraethylene glycol chains, α-cyclodextrin, and folic acid. In this study, folate groups on the mechanized hollow nanocontainers act as both the tumor-targeting agents and stoppers of the [2]rotaxanes. Detailed investigations showed that anticancer drug doxorubicin loaded mechanized nanocontainers could selectively induce the apoptosis and death of tumor cells. The drug-loaded nanocontainers enhanced the targeting capability to tumor tissues in vitro and inhibited the tumor growth with minimal side effects in vivo. The present controlled and targeted drug delivery system paves the way for developing the next generation of nanotherapeutics toward efficient cancer treatment.

Engineering multifunctional nanocarriers for targeted drug delivery shows promising potentials to revolutionize the cancer chemotherapy. Simple methods to optimize physicochemical characteristics and surface composition of the drug nanocarriers need to be developed in order to tackle major challenges for smooth translation of suitable nanocarriers to clinical applications. Here, rational development and utilization of multifunctional mesoporous silica nanoparticles (MSNPs) for targeting MDA‐MB‐231 xenograft model breast cancer in vivo are reported. Uniform and redispersible poly(ethylene glycol)‐incorporated MSNPs with three different sizes (48, 72, 100 nm) are synthesized. They are then functionalized with amino‐β‐cyclodextrin bridged by cleavable disulfide bonds, where amino‐β‐cyclodextrin blocks drugs inside the mesopores. The incorporation of active folate targeting ligand onto 48 nm of multifunctional MSNPs (PEG‐MSNPs48‐CD‐PEG‐FA) leads to improved and selective uptake of the nanoparticles into tumor. Targeted drug delivery capability of PEG‐MSNPs48‐CD‐PEG‐FA is demonstrated by significant inhibition of the tumor growth in mice treated with doxorubicin‐loaded nanoparticles, where doxorubicin is released triggered by intracellular acidic pH and glutathione. Doxorubicin‐loaded PEG‐MSNPs48‐CD‐PEG‐FA exhibits better in vivo therapeutic efficacy as compared with free doxorubicin and non‐targeted nanoparticles. Current study presents successful utilization of multifunctional MSNP‐based drug nanocarriers for targeted cancer therapy in vivo.